NCT02439333View on ClinicalTrials.gov

Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2019

Study Completion Date

July 15, 2019

Conditions
Lung Diseases, Obstructive
Interventions
DEVICE

Nasal high flow cannula (Fisher & Paykel Healthcare, Auckland, New Zealand)

Nasal high flow therapy

DEVICE

nasal catheter or Venturi mask

Conventional oxygen therapy

Trial Locations (1)

100020

Department of respiratory and critical care medicine,Beijing Chao-yang Hospital, Beijing

All Listed Sponsors
lead

Li Xuyan

OTHER

NCT02439333 - Prospective Randomized Study of Nasal High Flow in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter